amifostine anhydrous has been researched along with Kidney Failure, Chronic in 3 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Chronic administration of WR-2721 (20 mg = 0." | 1.27 | Protection from progressive renal failure and hyperparathyroid bone remodeling by WR-2721. ( Bonjour, JP; Caverzasio, J; Charhon, S; Hirschel-Scholz, S; Paunier, L; Rizzoli, R, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Treskes, M | 1 |
| van der Vijgh, WJ | 1 |
| Hirschel-Scholz, S | 1 |
| Charhon, S | 1 |
| Rizzoli, R | 1 |
| Caverzasio, J | 1 |
| Paunier, L | 1 |
| Bonjour, JP | 1 |
| Zingraff, J | 1 |
| Bourdeau, A | 1 |
| Clair, F | 1 |
| Kindermans, C | 1 |
| Buisson, C | 1 |
| Manganella, G | 1 |
| Sachs, C | 1 |
| Drüeke, T | 1 |
1 review available for amifostine anhydrous and Kidney Failure, Chronic
| Article | Year |
|---|---|
WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.
Topics: Amifostine; Animals; Bone Marrow Diseases; Carboplatin; Cisplatin; Ear Diseases; Gastrointestinal Di | 1993 |
2 other studies available for amifostine anhydrous and Kidney Failure, Chronic
| Article | Year |
|---|---|
Protection from progressive renal failure and hyperparathyroid bone remodeling by WR-2721.
Topics: Amifostine; Animals; Bone Resorption; Calcium; Hyperparathyroidism, Secondary; Kidney Failure, Chron | 1988 |
Hypocalcaemic effect of WR-2721, S-2 (3-aminopropylamino) ethyl-phosphorothioic acid in an anuric haemodialysis patient.
Topics: Amifostine; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; | 1987 |